Literature DB >> 14527840

Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers.

Virginia M Weaver1, Brian S Schwartz, Kyu-Dong Ahn, Walter F Stewart, Karl T Kelsey, Andrew C Todd, Jiayu Wen, David J Simon, Mark E Lustberg, Patrick J Parsons, Ellen K Silbergeld, Byung-Kook Lee.   

Abstract

We analyzed data from 798 lead workers to determine whether polymorphisms in the genes encoding delta-aminolevulinic acid dehydratase (ALAD), endothelial nitric oxide synthase (eNOS), and the vitamin D receptor (VDR) were associated with or modified relations of lead exposure and dose measures with renal outcomes. Lead exposure was assessed with job duration, blood lead, dimercaptosuccinic acid (DMSA)-chelatable lead, and tibia lead. Renal function was assessed with blood urea nitrogen (BUN), serum creatinine, measured creatinine clearance, calculated creatinine clearance and urinary N-acetyl-beta-D-glucosaminidase (NAG), and retinol-binding protein. Mean (+/- SD) tibia lead, blood lead, and DMSA-chelatable lead levels were 37.2 +/- 40.4 microg/g bone mineral, 32.0 +/- 15.0 microg/dL, and 767.8 +/- 862.1 microg/g creatinine, respectively. After adjustment, participants with the ALAD(2) allele had lower mean serum creatinine and higher calculated creatinine clearance. We observed effect modification by ALAD on associations between blood lead and/or DMSA-chelatable lead and three renal outcomes. Among those with the ALAD(1-2) genotype, higher lead measures were associated with lower BUN and serum creatinine and higher calculated creatinine clearance. Participants with the eNOS variant allele were found to have higher measured creatinine clearance and BUN. In participants with the Asp allele, longer duration working with lead was associated with higher serum creatinine and lower calculated creatinine clearance and NAG; all were significantly different from relations in those with the Glu/Glu genotype except NAG (p = 0.08). No significant differences were seen in renal outcomes by VDR genotype, nor was consistent effect modification observed. The ALAD findings could be explained by lead-induced hyperfiltration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527840      PMCID: PMC1241683          DOI: 10.1289/ehp.6116

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  44 in total

1.  Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.

Authors:  A Zanchi; D K Moczulski; L S Hanna; M Wantman; J H Warram; A S Krolewski
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

2.  A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors.

Authors:  H Hu
Journal:  Am J Dis Child       Date:  1991-06

3.  In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies.

Authors:  A C Todd; F E McNeill; J E Palethorpe; D E Peach; D R Chettle; M J Tobin; S J Strosko; J C Rosen
Journal:  Environ Res       Date:  1992-04       Impact factor: 6.498

4.  Attentional correlates of dentin and bone lead levels in adolescents.

Authors:  D Bellinger; H Hu; L Titlebaum; H L Needleman
Journal:  Arch Environ Health       Date:  1994 Mar-Apr

5.  In vivo measurements of lead in bone using a 109Cd 'spot' source.

Authors:  A C Todd; F E McNeill
Journal:  Basic Life Sci       Date:  1993

6.  Renal function and hyperfiltration capacity in lead smelter workers with high bone lead.

Authors:  H Roels; R Lauwerys; J Konings; J P Buchet; A Bernard; S Green; D Bradley; W Morgan; D Chettle
Journal:  Occup Environ Med       Date:  1994-08       Impact factor: 4.402

Review 7.  Renal abnormalities in sickle cell disease.

Authors:  M Allon
Journal:  Arch Intern Med       Date:  1990-03

8.  Experimental model of lead nephropathy. I. Continuous high-dose lead administration.

Authors:  F Khalil-Manesh; H C Gonick; A H Cohen; R Alinovi; E Bergamaschi; A Mutti; V J Rosen
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

9.  The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes.

Authors:  J G Wetmur; G Lehnert; R J Desnick
Journal:  Environ Res       Date:  1991-12       Impact factor: 6.498

10.  A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.

Authors:  C M Smith; X Wang; H Hu; K T Kelsey
Journal:  Environ Health Perspect       Date:  1995-03       Impact factor: 9.031

View more
  8 in total

1.  Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.

Authors:  Emily B Southard; Alanna Roff; Tracey Fortugno; John P Richie; Matthew Kaag; Vernon M Chinchilli; Jarmo Virtamo; Demetrius Albanes; Stephanie Weinstein; Robin Taylor Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-15       Impact factor: 4.254

2.  Association of renal function and delta-aminolevulinic acid dehydratase polymorphism among Vietnamese and Singapore workers exposed to inorganic lead.

Authors:  S-E Chia; H J Zhou; E Yap; M T Tham; N-V Dong; N T Hong Tu; K-S Chia
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

3.  Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey.

Authors:  Jeffrey J Fadrowski; Ana Navas-Acien; Maria Tellez-Plaza; Eliseo Guallar; Virginia M Weaver; Susan L Furth
Journal:  Arch Intern Med       Date:  2010-01-11

Review 4.  The protean toxicities of lead: new chapters in a familiar story.

Authors:  David C Bellinger
Journal:  Int J Environ Res Public Health       Date:  2011-06-27       Impact factor: 3.390

5.  Associations of uric acid with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers.

Authors:  Virginia M Weaver; Brian S Schwartz; Bernard G Jaar; Kyu-Dong Ahn; Andrew C Todd; Sung-Soo Lee; Karl T Kelsey; Ellen K Silbergeld; Mark E Lustberg; Patrick J Parsons; Jiayu Wen; Byung-Kook Lee
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

6.  Possible influence of delta-aminolevulinic acid dehydratase polymorphism and susceptibility to renal toxicity of lead: a study of a Vietnamese population.

Authors:  Sin Eng Chia; Huijun Zhou; Mei Theng Tham; Eric Yap; Nguyen-Viet Dong; Nguyenthi Hong Tu; Kee Seng Chia
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

7.  Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels.

Authors:  Claire de Burbure; Jean-Pierre Buchet; Ariane Leroyer; Catherine Nisse; Jean-Marie Haguenoer; Antonio Mutti; Zdenek Smerhovsky; Miroslav Cikrt; Malgorzata Trzcinka-Ochocka; Grazyna Razniewska; Marek Jakubowski; Alfred Bernard
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

8.  Lead and delta-aminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis.

Authors:  Franco Scinicariello; H Edward Murray; Daphne B Moffett; Henry G Abadin; Mary J Sexton; Bruce A Fowler
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.